Sue's Story: A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente and other health systems; in nursing programs offered by ...

The team will look at new and existing blood tests, looking at a range of dementia types including Alzheimer’s disease, ...

Jan. 10, 2025 — Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia ...

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

Cognition Therapeutics, Inc. announced promising results from the SHIMMER study of zervimesine (CT1812) in patients with mild-to-moderate dementia with Lewy bodies (DLB), to be presented by Dr ...

The details of the presentation will be accessible in the Investor section of the CervoMed website following the presentation. CervoMed Inc. is a clinical-stage company focused on developing ...

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from ...

A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente ...

The initial topline results for the Phase 2b study of neflamapimod in dementia with Lewy bodies (DLB) were previously disclosed on December 10, 2024 and are available here. CervoMed Inc. is a ...

Jan. 28, 2025 /PRNewswire/ -- Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's Story: A Journey with Lewy Body Dementia ...